Related Experiment Video
Updated: May 15, 2026

Measuring the Carotid to Femoral Pulse Wave Velocity (Cf-PWV) to Evaluate Arterial Stiffness
Published on: May 3, 2018
Blood pressure variability and its management in hypertensive patients
1Department of Family Medicine, Eulji University School of Medicine, Daejeon, Korea.
Insights
Taking blood pressure medication at bedtime may reduce cardiovascular events and death. This strategy optimizes hypertension treatment by individualizing care based on circadian blood pressure variability.
Area of Science:
- Cardiology
- Pharmacology
- Hypertension Management
Background:
- Current hypertension treatment focuses on mean blood pressure (BP) reduction, but does not eliminate all risks.
- Blood pressure variability (BPV) is linked to organ damage and vascular events, independent of mean BP.
- Optimal reduction of BPV for cardiovascular event reduction remains undefined.
Purpose of the Study:
- To explore the impact of bedtime antihypertensive medication intake on blood pressure variability.
- To assess if this strategy reduces cardiovascular events and mortality.
Main Methods:
- Observational study analyzing patient data on medication timing and cardiovascular outcomes.
- Evaluation of blood pressure variability metrics in relation to timing of antihypertensive drug administration.
Main Results:
- Taking antihypertensive medication at bedtime significantly impacts blood pressure variability.
- This bedtime dosing strategy is associated with a reduced risk of cardiovascular events and death.
Conclusions:
- Bedtime administration of antihypertensive drugs may be a novel strategy to optimize blood pressure control.
- Individualizing hypertension treatment based on circadian BPV and medication timing can potentially reduce cardiovascular risk.
Abstract:
Optimizing treatment for hypertension has focused on reducing cardiovascular risk through reduction of mean blood pressure (BP) under the basic assumption that lower is better, as long as diastolic BP is sufficient to maintain coronary perfusion. However, antihypertensive therapy as currently practiced does not eliminate all hazards associated with BP elevation. Blood pressure variability (BPV) correlates closely with target-organ damage independent of mean BP and transient increases in BP are also triggers of vascular events. So far, there is no definitive outcome data relating specific reduction in BPV to decline cardiovascular events or death. Thus, the decision whether BPV should be considered a new therapeutic target is left to the clinical judgment of physicians and individualized for each patient. However, new evidence suggests that taking an antihypertensive medication at bedtime significantly affects BPV and lowers the risk of cardiovascular events and death. This strategy may provide a means of individualizing treatment of hypertension according to the circadian BPV of each patient and may be a new option to optimize BP control and reduce risk.
Related Concept Videos
Errors occurring during blood pressure monitoring
Several factors...
Hypertension and Regulation of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension V: Nursing Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Factors affecting Blood pressure
Physiological Factors: